Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis
Meta-analysis of >87,000 patients demonstrates that patients with invasive lobular carcinoma of the breast are far less likely to achieve pCR of the breast or axilla compared to their ductal counterparts, receive less BCS and more frequently return positive margins. Background: Neoadjuvant chemot...
Guardado en:
Autores principales: | Dómhnall J. O'Connor, Matthew G. Davey, Laura R. Barkley, Michael J. Kerin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5f6026ac12d4487a2bdc790bef67ce5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma
por: Mary Kathryn Abel, et al.
Publicado: (2021) -
Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
por: Tian Du, et al.
Publicado: (2018) -
Pleomorphic lobular carcinoma: is it more similar to a classic lobular cancer or to a high-grade ductal cancer?
por: Costarelli L, et al.
Publicado: (2017) -
Sonomammographic characteristics of invasive lobular carcinoma
por: El-Damshety O, et al.
Publicado: (2012) -
Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes
por: Mayu Hosio, et al.
Publicado: (2021)